Skip to main content
Signal8

ORBIMED ADVISORS LLC

ORBIMED ADVISORS LLC is an Investment Adviser institutional filer with the SEC under CIK 1055951, reporting 121 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in ORBIMED ADVISORS LLC's most recent 13F filing, ranked by reported market value.

  1. EDGEWISE THERAPEUTICS INC (EWTX)
  2. ENLIVEN THERAPEUTICS INC (ELVN)
  3. ELI LILLY & CO (LLY)
  4. MBX BIOSCIENCES INC (MBX)
  5. SINOVAC BIOTECH LTD (SVA)
  6. ASTRAZENECA PLC (AZN)
  7. STRUCTURE THERAPEUTICS INC (GPCR)
  8. SIONNA THERAPEUTICS INC (SION)
  9. CORVUS PHARMACEUTICALS INC (CRVS)
  10. ARRIVENT BIOPHARMA INC (AVBP)
/